Envestnet Asset Management
BNTX icon

Envestnet Asset Management’s BioNTech BNTX Stock Holding History

Envestnet Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,948
Closed -$706K – 4839
2026
Q1 		$706K Buy
+7,948
New +$817K ﹤0.01% 3688
2025
Q4 		– Sell
-8,355
Closed -$824K – 4478
2025
Q3 		$824K Sell
8,355
-2,215
-21% -$237K ﹤0.01% 3441
2025
Q2 		$1.13M Buy
10,570
+1,808
+21% +$183K ﹤0.01% 3217
2025
Q1 		$798K Sell
8,762
-11,715
-57% -$1.31M ﹤0.01% 3345
2024
Q4 		$2.33M Sell
20,477
-476
-2% -$54.3K ﹤0.01% 2594
2024
Q3 		$2.49M Sell
20,953
-100,228
-83% -$9.21M ﹤0.01% 2515
2024
Q2 		$9.74M Sell
121,181
-9,160
-7% -$837K ﹤0.01% 1582
2024
Q1 		$12M Buy
130,341
+6,646
+5% +$637K ﹤0.01% 1411
2023
Q4 		$13.1M Buy
123,695
+110,314
+824% +$11.1M 0.01% 1280
2023
Q3 		$1.45M Sell
13,381
-2,547
-16% -$282K ﹤0.01% 2548
2023
Q2 		$1.72M Sell
15,928
-956,607
-98% -$108M ﹤0.01% 2368
2023
Q1 		$1.53M Buy
972,535
+952,932
+4,861% +$131M ﹤0.01% 2369
2022
Q4 		$2.94M Buy
19,603
+153
+0.8% +$23.5K ﹤0.01% 1916
2022
Q3 		$2.62M Buy
19,450
+4,742
+32% +$725K ﹤0.01% 1915
2022
Q2 		$2.19M Buy
14,708
+1,668
+13% +$255K ﹤0.01% 2042
2022
Q1 		$2.22M Sell
13,040
-12,298
-49% -$2.07M ﹤0.01% 2134
2021
Q4 		$6.53M Buy
25,338
+7,542
+42% +$2.07M ﹤0.01% 1435
2021
Q3 		$4.86M Buy
17,796
+3,391
+24% +$1.08M ﹤0.01% 1571
2021
Q2 		$3.23M Buy
14,405
+7,731
+116% +$1.46M ﹤0.01% 1769
2021
Q1 		$729K Buy
+6,674
New +$709K ﹤0.01% 2620

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Envestnet Asset Management's BNTX Position: Q2 2026 in Review

Envestnet Asset Management sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 7,948 shares — an estimated $706K sold.

Envestnet Asset Management first reported a position in BNTX in Q1 2021 and held it in 20 quarters. The position peaked at $13.1M in Q4 2023. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Envestnet Asset Management reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 7,948 BioNTech shares in Q2 2026, an estimated $706K.
  • Envestnet Asset Management first reported a position in BioNTech in Q1 2021 and held it in 20 quarters.
  • Envestnet Asset Management's BioNTech position peaked at $13.1M in Q4 2023.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.